FAIM
REGN icon

Financial Advocates Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Financial Advocates Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-691
Closed -$438K – 737
2025
Q1 		$438K Buy
691
+26
+4% +$17.9K 0.03% 454
2024
Q4 		$474K Buy
+665
New +$558K 0.03% 466
2024
Q2 		– Sell
-392
Closed -$377K – 811
2024
Q1 		$377K Sell
392
-1
-0.3% -$951 0.02% 523
2023
Q4 		$345K Buy
393
+80
+26% +$65.9K 0.02% 509
2023
Q3 		$258K Buy
313
+4
+1% +$3.14K 0.02% 570
2023
Q2 		$222K Sell
309
-90
-23% -$69.4K 0.02% 616
2023
Q1 		$328K Buy
+399
New +$301K 0.02% 528
2022
Q2 		– Sell
-287
Closed -$200K – 770
2022
Q1 		$200K Buy
+287
New +$182K 0.01% 687
2021
Q4 		– Sell
-492
Closed -$298K – 806
2021
Q3 		$298K Buy
492
+47
+11% +$29.2K 0.02% 618
2021
Q2 		$248K Buy
+445
New +$225K 0.02% 649

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Financial Advocates Investment Management's REGN Position: Q2 2025 in Review

Financial Advocates Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 691 shares — an estimated $438K sold.

Financial Advocates Investment Management first reported a position in REGN in Q2 2021 and held it in 10 quarters. The position peaked at $474K in Q4 2024. 1,203 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

  • Financial Advocates Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Financial Advocates Investment Management sold 691 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $438K.
  • Financial Advocates Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2021 and held it in 10 quarters.
  • Financial Advocates Investment Management's Regeneron Pharmaceuticals position peaked at $474K in Q4 2024.
  • 1,203 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Financial Advocates Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.